Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.
Unknown statusPhase 1, Phase 2NCT06431165
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study aimed To investigate the effects of different doses of Intraoperative intravenous lidocaine infusion on intraoperative opioid consumption, perioperative pain control and incidence of postoperative chronic pain.
Study details
- Official title
- Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.
- Conditions
- Perioperative Pain Management
- Interventions
- Drug: Lidocaine IV
- Sponsor
- Cairo University
- Start date
- 2024-03-15
- Primary completion
- 2025-03
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients age between 18 and 65. * Patients with ASA I and II status. * Patients undergoing open laparotomy surgeries (including open cholecystectomies). Exclusion Criteria: * Patients unable to comprehend the informed consent. * Patients on long term pre-operative opioid regimens. * Patients with impairment in hepatic or renal functions. * Patients who are planned to receive any form of regional block for the surgery.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06431165